Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting
Publication
, Conference
Cavallari, LH; Denny, JC; Lee, CR; Beitelshees, AL; Duarte, JD; Kimmel, SE; Voora, D; McDonough, CW; Gong, Y; Wei, W-Q; Pratt, VM; Coons, JC ...
Published in: CIRCULATION
December 20, 2016
Duke Scholars
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 20, 2016
Volume
134
Issue
25
Start / End Page
E711 / E712
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Cavallari, L. H., Denny, J. C., Lee, C. R., Beitelshees, A. L., Duarte, J. D., Kimmel, S. E., … Peterson, J. F. (2016). Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting. In CIRCULATION (Vol. 134, pp. E711–E712). New Orleans, LA: LIPPINCOTT WILLIAMS & WILKINS.
Cavallari, Larisa H., Joshua C. Denny, Craig R. Lee, Amber L. Beitelshees, Julio D. Duarte, Steve E. Kimmel, Deepak Voora, et al. “Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting.” In CIRCULATION, 134:E711–12. LIPPINCOTT WILLIAMS & WILKINS, 2016.
Cavallari LH, Denny JC, Lee CR, Beitelshees AL, Duarte JD, Kimmel SE, et al. Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. E711–2.
Cavallari, Larisa H., et al. “Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting.” CIRCULATION, vol. 134, no. 25, LIPPINCOTT WILLIAMS & WILKINS, 2016, pp. E711–12.
Cavallari LH, Denny JC, Lee CR, Beitelshees AL, Duarte JD, Kimmel SE, Voora D, McDonough CW, Gong Y, Wei W-Q, Pratt VM, Chumnumwat S, Coons JC, Cooper-DeHoff RM, Dave CV, Dillon C, Hamadeh IS, Hines L, Howell LA, Jeng LJ, Lee YM, Skaar TC, Sriramoju VB, Stevenson JM, Vesely MR, Wake D, Kreutz RP, Stouffer GA, Wilke RA, Empey PE, Limdi NA, Roden DM, Shuldiner AR, Johnson JA, Peterson JF. Prospective Clinical Implementation of CYP2C19-Genotype Guided Antiplatelet Therapy After PCI: a Multi-Site Investigation of MACE Outcomes in a Real-World Setting. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016. p. E711–E712.
Published In
CIRCULATION
EISSN
1524-4539
ISSN
0009-7322
Publication Date
December 20, 2016
Volume
134
Issue
25
Start / End Page
E711 / E712
Location
New Orleans, LA
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Conference Name
Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology